{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:47:52Z","timestamp":1788058072574,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32172917"],"award-info":[{"award-number":["32172917"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"crossref","award":["PAPD"],"award-info":[{"award-number":["PAPD"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Ningxia Hui Autonomous Region","award":["No. 2024AAC05098"],"award-info":[{"award-number":["No. 2024AAC05098"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["KYCXJC2025001"],"award-info":[{"award-number":["KYCXJC2025001"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"DOI":"10.1186\/s12917-025-04975-7","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:55:51Z","timestamp":1758740151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PlyNJ3: a three-domain endolysin with broad-spectrum anti-streptococcal activity and synergistic efficacy against multidrug-resistant Streptococcus suis"],"prefix":"10.1186","volume":"21","author":[{"given":"Jiaqi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shushu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"5944","key":"4975_CR1","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.1176667","volume":"325","author":"MA Fischbach","year":"2009","unstructured":"Fischbach MA, Walsh CT. Antibiotics for emerging pathogens. Science. 2009;325(5944):1089\u201393.","journal-title":"Science"},{"key":"4975_CR2","doi-asserted-by":"crossref","unstructured":"Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45(6):568\u201385.","DOI":"10.1016\/j.ijantimicag.2015.03.001"},{"issue":"5","key":"4975_CR3","first-page":"344","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. P T. 2015;40(5):344\u201352.","journal-title":"P T"},{"key":"4975_CR4","doi-asserted-by":"crossref","unstructured":"Danis-Wlodarczyk KM, Wozniak DJ, Abedon ST. Treating bacterial infections with bacteriophage-based enzybiotics: in vitro, in vivo and clinical application. Antibiotics. 2021;10(12): 1497.","DOI":"10.3390\/antibiotics10121497"},{"key":"4975_CR5","doi-asserted-by":"crossref","unstructured":"Kim BO, Kim ES, Yoo YJ, Bae HW, Chung IY, Cho YH. Phage-derived antibacterials: harnessing the simplicity, plasticity, and diversity of phages. Viruses. 2019;11(3): 268.","DOI":"10.3390\/v11030268"},{"issue":"2","key":"4975_CR6","doi-asserted-by":"publisher","first-page":"24478","DOI":"10.31083\/FBL24478","volume":"30","author":"OI Guliy","year":"2025","unstructured":"Guliy OI, Evstigneeva SS. Bacteria-and phage-derived proteins in phage infection. Front Biosci (Landmark Ed). 2025;30(2):24478.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4975_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/B978-0-12-394438-2.00007-4","volume":"83","author":"DC Nelson","year":"2012","unstructured":"Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, Dong S, Donovan DM. Endolysins as antimicrobials. Adv Virus Res. 2012;83:299\u2013365.","journal-title":"Adv Virus Res"},{"issue":"5","key":"4975_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/microorganisms8050724","volume":"8","author":"Y Chang","year":"2020","unstructured":"Chang Y. Bacteriophage-derived endolysins applied as potent biocontrol agents to enhance food safety. Microorganisms. 2020;8(5):724.","journal-title":"Microorganisms"},{"issue":"10","key":"4975_CR9","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1007\/s00253-012-4294-7","volume":"97","author":"M Walmagh","year":"2013","unstructured":"Walmagh M, Boczkowska B, Grymonprez B, Briers Y, Drulis-Kawa Z, Lavigne R. Characterization of five novel endolysins from Gram-negative infecting bacteriophages. Appl Microbiol Biotechnol. 2013;97(10):4369\u201375.","journal-title":"Appl Microbiol Biotechnol"},{"key":"4975_CR10","doi-asserted-by":"crossref","unstructured":"Oliveira H, Melo LD, Santos SB, N\u00f3brega FL, Ferreira EC, Cerca N, Azeredo J, Kluskens LD. Molecular aspects and comparative genomics of bacteriophage endolysins. J Virol. 2013;87(8):4558\u201370.","DOI":"10.1128\/JVI.03277-12"},{"issue":"10","key":"4975_CR11","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2217\/fmb.12.97","volume":"7","author":"M Schmelcher","year":"2012","unstructured":"Schmelcher M, Donovan DM, Loessner MJ. Bacteriophage endolysins as novel antimicrobials. Future Microbiol. 2012;7(10):1147\u201371.","journal-title":"Future Microbiol"},{"key":"4975_CR12","doi-asserted-by":"crossref","unstructured":"S\u00e3o-Jos\u00e9 C. Engineering of phage-derived lytic enzymes: improving their potential as antimicrobials. Antibiotics. 2018;7(2): 29.","DOI":"10.3390\/antibiotics7020029"},{"key":"4975_CR13","doi-asserted-by":"crossref","unstructured":"Vander Elst N, Linden SB, Lavigne R, Meyer E, Briers Y, Nelson DC. Characterization of the bacteriophage-derived endolysins PlySs2 and PlySs9 with in vitro lytic activity against bovine mastitis Streptococcus uberis. Antibiotics. 2020;9(9): 621.","DOI":"10.3390\/antibiotics9090621"},{"key":"4975_CR14","doi-asserted-by":"crossref","unstructured":"Gupta R, Prasad Y. P-27\/HP endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections. Curr Microbiol. 2011;63(1):39\u201345.","DOI":"10.1007\/s00284-011-9939-8"},{"key":"4975_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.copbio.2020.09.012","volume":"68","author":"M Schmelcher","year":"2021","unstructured":"Schmelcher M, Loessner MJ. Bacteriophage endolysins-extending their application to tissues and the bloodstream. Curr Opin Biotechnol. 2021;68:51\u20139.","journal-title":"Curr Opin Biotechnol"},{"key":"4975_CR16","doi-asserted-by":"crossref","unstructured":"Oechslin F, Daraspe J, Giddey M, Moreillon P, Resch G. In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia. Antimicrob Agents Chemother. 2013;57(12):6276\u201383.","DOI":"10.1128\/AAC.01701-13"},{"key":"4975_CR17","doi-asserted-by":"crossref","unstructured":"Park S, Jun SY, Kim CH, Jung GM, Son JS, Jeong ST, Yoon SJ, Lee SY, Kang SH. Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis. Sci Rep. 2018;8(1):18.","DOI":"10.1038\/s41598-017-18535-z"},{"issue":"4","key":"4975_CR18","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/v13040680","volume":"13","author":"E Murray","year":"2021","unstructured":"Murray E, Draper LA, Ross RP, Hill C. The advantages and challenges of using endolysins in a clinical setting. Viruses. 2021;13(4):680.","journal-title":"Viruses"},{"key":"4975_CR19","doi-asserted-by":"crossref","unstructured":"Zhang L, Li D, Li X, Hu L, Cheng M, Xia F, Gong P, Wang B, Ge J, Zhang H, Cai R, Wang Y, Sun C, Feng X, Lei L, Han W, Gu J. LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation. Sci Rep. 2016;6:29344.","DOI":"10.1038\/srep29344"},{"key":"4975_CR20","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Rubio L, Mart\u00ednez B, Donovan DM, Rodr\u00edguez A, Garc\u00eda P. Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit Rev Microbiol. 2013;39(4):427\u201334.","DOI":"10.3109\/1040841X.2012.723675"},{"key":"4975_CR21","doi-asserted-by":"crossref","unstructured":"Raz A, Serrano A, Hernandez A, Euler CW, Fischetti VA. Isolation of phage lysins that effectively kill Pseudomonas aeruginosa in mouse models of lung and skin infection. Antimicrob Agents Chemother. 2019;63(7):e00024-19.","DOI":"10.1128\/AAC.00024-19"},{"key":"4975_CR22","doi-asserted-by":"crossref","unstructured":"Yang H, Wang M, Yu J, Wei H. Antibacterial activity of a novel peptide-modified lysin against Acinetobacter baumannii and Pseudomonas aeruginosa. Front Microbiol. 2015;6:1471.","DOI":"10.3389\/fmicb.2015.01471"},{"key":"4975_CR23","doi-asserted-by":"crossref","unstructured":"Lai WCB, Chen X, Ho MKY, Xia J, Leung SSY. Bacteriophage-derived endolysins to target gram-negative bacteria. Int J Pharm. 2020;589: 119833.","DOI":"10.1016\/j.ijpharm.2020.119833"},{"key":"4975_CR24","doi-asserted-by":"crossref","unstructured":"Sundarrajan S, Raghupatil J, Vipra A, Narasimhaswamy N, Saravanan S, Appaiah C, Poonacha N, Desai S, Nair S, Bhatt RN, Roy P, Chikkamadaiah R, Durgaiah M, Sriram B, Padmanabhan S, Sharma U. Bacteriophage-derived CHAP domain protein, P128, kills Staphylococcus cells by cleaving interpeptide cross-bridge of peptidoglycan. Microbiology. 2014;160(Pt 10):2157\u201369.","DOI":"10.1099\/mic.0.079111-0"},{"key":"4975_CR25","doi-asserted-by":"crossref","unstructured":"Kim NH, Park WB, Cho JE, Choi YJ, Choi SJ, Jun SY, Kang CK, Song KH, Choe PG, Bang JH, Kim ES, Park SW, Kim NJ, Oh MD, Kim HB. Effects of phage endolysin SAL200 combined with antibiotics on Staphylococcus aureus infection. Antimicrob Agents Chemother. 2018;62(10):e00731-18.","DOI":"10.1128\/AAC.00731-18"},{"key":"4975_CR26","doi-asserted-by":"crossref","unstructured":"Schuch R, Lee HM, Schneider BC, Sauve KL, Law C, Khan BK, Rotolo JA, Horiuchi Y, Couto DE, Raz A, Fischetti VA, Huang DB, Nowinski RC, Wittekind M. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia. J Infect Dis. 2014;209(9):1469\u201378.","DOI":"10.1093\/infdis\/jit637"},{"issue":"2","key":"4975_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000473872","volume":"9","author":"JEE Tott\u00e9","year":"2017","unstructured":"Tott\u00e9 JEE, van Doorn MB, Pasmans SGMA. Successful treatment of chronic Staphylococcus aureus-related dermatoses with the topical endolysin staphefekt SA.100: a report of 3 cases. Case Rep Dermatol. 2017;9(2):19\u201325.","journal-title":"Case Rep Dermatol"},{"key":"4975_CR28","doi-asserted-by":"crossref","unstructured":"Cill\u00f3niz C, Garcia-vidal C, Ceccato A, Torres A. Antimicrobial resistance among Streptococcus pneumoniae. In: Fong I, Shlaes D, Drlica K, editors. Antimicrobial Resistance in the 21st Century. Emerging Infectious Diseases of the 21st Century. Cham:\u00a0Springer; 2018. p. 13-38.","DOI":"10.1007\/978-3-319-78538-7_2"},{"key":"4975_CR29","doi-asserted-by":"crossref","unstructured":"Yu H, Jing H, Chen Z, Zheng H, Zhu X, Wang H, Wang S, Liu L, Zu R, Luo L, Xiang N, Liu H, Liu X, Shu Y, Lee SS, Chuang SK, Wang Y, Xu J, Yang W, Streptococcus suis study groups. Human Streptococcus suis outbreak, Sichuan, China. Emerg Infect Dis. 2006;12(6):914\u201320.","DOI":"10.3201\/eid1206.051194"},{"key":"4975_CR30","doi-asserted-by":"crossref","unstructured":"Feng Y, Zhang H, Wu Z, Wang S, Cao M, Hu D, Wang C. Streptococcus suis infection: an emerging\/reemerging challenge of bacterial infectious diseases? Virulence. 2014;5(4):477\u201397.","DOI":"10.4161\/viru.28595"},{"key":"4975_CR31","doi-asserted-by":"crossref","unstructured":"Huang J, Dai X, Wu Z, Hu X, Sun J, Tang Y, Zhang W, Han P, Zhao J, Liu G, Wang X, Mao S, Wang Y, Call DR, Liu J, Wang L. Conjugative transfer of Streptococcal prophages harboring antibiotic resistance and virulence genes. ISME J. 2023;17(9):1467\u201381.","DOI":"10.1038\/s41396-023-01463-4"},{"key":"4975_CR32","doi-asserted-by":"crossref","unstructured":"Oliveira H, S\u00e3o-Jos\u00e9 C, Azeredo J. Phage-derived peptidoglycan degrading enzymes: challenges and future prospects for in vivo therapy. Viruses. 2018;10(6):292.","DOI":"10.3390\/v10060292"},{"key":"4975_CR33","doi-asserted-by":"crossref","unstructured":"Donovan DM, Foster-Frey J, Dong S, Rousseau GM, Moineau S, Pritchard DG. The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase\/peptidase domain. Appl Environ Microbiol. 2006;72(7):5108\u201312.","DOI":"10.1128\/AEM.03065-05"},{"key":"4975_CR34","doi-asserted-by":"crossref","unstructured":"Son B, Kong M, Lee Y, Ryu S. Development of a novel chimeric endolysin, Lys109 with enhanced lytic activity against Staphylococcus aureus. Front Microbiol. 2021;11:615887.","DOI":"10.3389\/fmicb.2020.615887"},{"key":"4975_CR35","doi-asserted-by":"crossref","unstructured":"Muharram MM, Abulhamd AT, Aldawsari MF, Alqarni MH, Labrou NE. Development of Staphylococcus enzybiotics: the Ph28 gene of Staphylococcus epidermidis phage PH15 is a two-domain endolysin. Antibiotics. 2020;9(4): 148.","DOI":"10.3390\/antibiotics9040148"},{"issue":"5","key":"4975_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.mib.2008.09.012","volume":"11","author":"VA Fischetti","year":"2008","unstructured":"Fischetti VA. Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol. 2008;11(5):393\u2013400.","journal-title":"Curr Opin Microbiol"},{"issue":"6","key":"4975_CR37","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00253-006-0771-1","volume":"74","author":"Q Cheng","year":"2007","unstructured":"Cheng Q, Fischetti VA. Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B Streptococci. Appl Microbiol Biotechnol. 2007;74(6):1284\u201391.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"4975_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/v11020096","volume":"11","author":"K Abdelkader","year":"2019","unstructured":"Abdelkader K, Gerstmans H, Saafan A, Dishisha T, Briers Y. The preclinical and clinical progress of bacteriophages and their lytic enzymes: the parts are easier than the whole. Viruses. 2019;11(2):96.","journal-title":"Viruses"},{"key":"4975_CR39","doi-asserted-by":"crossref","unstructured":"Seroussi E, Blum SE, Krifucks O, Shirak A, Jacoby S, Leitner G. Basal levels of CD18 antigen presenting cells in cow milk associate with copy number variation of FC gamma receptors. Genes. 2020;11(8): 952.","DOI":"10.3390\/genes11080952"},{"key":"4975_CR40","doi-asserted-by":"crossref","unstructured":"Gilmer DB, Schmitz JE, Euler CW, Fischetti VA. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2013;57(6):2743\u201350.","DOI":"10.1128\/AAC.02526-12"},{"key":"4975_CR41","doi-asserted-by":"crossref","unstructured":"Nelson D, Loomis L, Fischetti VA. Prevention and elimination of upper respiratory colonization of mice by group A Streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A. 2001;98(7):4107\u201312.","DOI":"10.1073\/pnas.061038398"},{"key":"4975_CR42","doi-asserted-by":"crossref","unstructured":"Scholte CM, Nelson DC, Garcia M, Linden SB, Elsasser TH, Kahl S, Qu Y, Moyes KM. Short communication: Recombinant bacteriophage endolysin plyc is nontoxic and does not alter blood neutrophil oxidative response in lactating dairy cows. J Dairy Sci. 2018;101(7):6419\u201323.","DOI":"10.3168\/jds.2017-13908"},{"key":"4975_CR43","doi-asserted-by":"crossref","unstructured":"Loeffler JM, Nelson D, Fischetti VA. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science. 2001;294(5549):2170\u20132.","DOI":"10.1126\/science.1066869"},{"issue":"11","key":"4975_CR44","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1128\/IAI.71.11.6199-6204.2003","volume":"71","author":"JM Loeffler","year":"2003","unstructured":"Loeffler JM, Djurkovic S, Fischetti VA. Phage lytic enzyme Cpl-1 as a novel antimicrobial for Pneumococcal bacteremia. Infect Immun. 2003;71(11):6199\u2013204.","journal-title":"Infect Immun"},{"key":"4975_CR45","doi-asserted-by":"crossref","unstructured":"Lood R, Raz A, Molina H, Euler CW, Fischetti VA. A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against Streptococcal bacteremia. Antimicrob Agents Chemother. 2014;58(6):3073\u201384.","DOI":"10.1128\/AAC.00115-14"},{"key":"4975_CR46","doi-asserted-by":"crossref","unstructured":"Cheng Q, Nelson D, Zhu S, Fischetti VA. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother. 2005;49(1):111\u20137.","DOI":"10.1128\/AAC.49.1.111-117.2005"},{"key":"4975_CR47","doi-asserted-by":"crossref","unstructured":"Pritchard DG, Dong S, Baker JR, Engler JA. The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology. 2004;150(7):2079\u201387.","DOI":"10.1099\/mic.0.27063-0"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-04975-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-025-04975-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-04975-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:55:59Z","timestamp":1758740159000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-025-04975-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4975"],"URL":"https:\/\/doi.org\/10.1186\/s12917-025-04975-7","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were carried out at the Laboratory Animal Center of Nanjing Agricultural University, according to the guidelines of Experimental Animal Management Measures of Jiangsu Province and were approved by the Laboratory Animal Monitoring Committee of Jiangsu Province, China [Permit number: SYXK (Su) 2021-0086].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"540"}}